Home
About NF Inc. MN
Join NF
Events
Contact Us
Health Professionals
Glossary
Publications
Research
Links
Resources
Clinical Trials
Personal Stories

NF1 Clinical Trials

Opportunities to Participate in NF Research (PDF format)
Posted November 2004

Clinical Trials Sponsored by the National Institutes of Health

  • Dermal Neurofibroma (cutaneous/subcutaneous)

            Study of Neurofibroma Growth in Adults with Neurofibromatosis Type 1

            Mechanical Trauma in Neurofibroma Formation

  • Plexiform Neurofibroma

            AZD2171 in Treating Patients with NF1 and Plexiform Neurofibroma and/or Neurofibroma Near the Spine

            Pirfenidone in Children and Young Adults with NF1 and Progressive Plexiform Neurofibromas

            A Phase II Clinical Trial of Pirfenidone for the Treatment of Patients with NF1

            Tipifarnib (R115777) to Treat Children with NF1 and Progressive Plexiform Neurofibromas

            Combination Chemotherapy in Treating Patients with NF and Progressive Plexiform Neurofibromas

            Novel Imaging Modalities for Plexiform Neurofibroma

            Fludeoxyglucose F 18 Positron Emission Tomography and Magnetic Resonance Perfusion Imaging in Patients With
           
 Neurofibromatosis 1 and Plexiform Neurofibroma

 

  • Spinal Neurofibromas

            A Phase II Clinical Trial of Perfenidone for the Treatment of Patients with NF1
 

  • Visual Pathway Glioma

            Temozolomide in Treating Patients with Progressive Low-Grade Glioma

            Thalidomide and Temozolomide in Treating Young Patients with Relapsed or Progressive Brain

  Tumors or Recurrent Neuroblastoma
 

  • Pheochromocytoma

            Diagnosis of Pheochromocytoma

            131MIBG to Treat Malignant Pheochromocytoma

  • Malignant Peripheral Nerve Sheath Tumors (MPNST)

            Combination Chemotherapy in Treating Patients with Stage III or Stage IV Malignant Peripheral Nerve Sheath Tumors

   MPNSTs)

            Epirubicin (Ellence) for Advanced Soft Tissue Sarcoma

            Erlotinib and Temozolomide in Treating Young Patients With Recurrent or Refractory Solid Tumors

            Chemotherapy Before Surgery to Treat Malignant Peripheral Nerve Sheath Tumor

  • Natural History (NF1)

            Variation in Gene Expression in NF1

            Quantitative Phenotyping and Genotype-Phenotype Correlations in NF1

            Study of Disease Severity in Adults with Neurofibromatosis Type 1 (NF1)

            Natural History and Biology of Skin Neurofibromas in Neurofibromatosis Type 1

  • Other Tumors

            Call for NF1 Tumor Donations (Research Call)

            Neurofibroma Tissue Needed from NF1 Patients (Research Call)

  • Bone Manifestations

            Multicenter Study of Tibial Dysplasia in NF1 Patients (Research Call)

            Bone Density Study in Houston (Research Call)

  • Other Manifestations

            Research Study Investigating the Variability of Families with NF1 (Research Call)

            Families with NF1 and Colon Cancer Needed for a New Research Study (Research Call)

  • Cognitive Disorders

            Trial to Evaluate the Safety of Lovastatin in Adults with Neurofibromatosis Type I (NF1)

            NF1-Attention: Study of Children With Neurofibromatosis Type 1 Treated by Methylphenidate

            Phase I Study of Lovastatin for Neurocognitive Dysfunction in Children with NF1

            Early Identification of Cognitive Deficits in Children with NF1

            Functional MRI in Children with ADHD and NF1 (Research Call)

            Attention Families of Children With Neurofibromatosis Type 1 (Ages 7 to 16)